Hyadd4 (sodium hyaluronate hexadecylamide)

HYMOVIS is the latest generation hyaluronic acid-based product that, thanks to its innovative, patented technology (MO.RE Technology), guarantees
  • prompt answer to joint pain
  • high and long-lasting benefit
  • high safety profile

HYMOVIS is the only hyaluronic acid brand which demonstrates structure recovery even after repetitive mechanical stress, high viscoelastic properties and long-lasting effect, while maintaining its biological activity

For more information about Hymovis, visit www.hymovis.ru (in Russian)

- Latest generation hyaluronic acid
- Innovative premium intra-articular hyaluronan
- For high-demand patients

Farmaceutici S.p.A.

Find out our Corporate Website:

Go to the website

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Russia product portfolio focalizes primarily on joint healthcare.

Fidia Pharma Russia is focused on providing consumers with innovative products that offer quality, safety and performance.